Neutra Corp. balance sheet NTRR

Annual Quarterly

As of Oct 31, 2023, Neutra Corp. had total assets of $26,944 and total liabilities of $962,984. Total assets were down 72.5% from a year earlier. Stockholders' equity was negative, at -$936,040, because liabilities exceed assets. Cash and investments were $692. The current ratio, current assets divided by current liabilities, was 0.02.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line	FY 2024 Oct 31, 2023	FY 2023 Jan 31, 2023	FY 2022 Jan 31, 2022	FY 2021 Jan 31, 2021	FY 2020 Jan 31, 2020	FY 2019 Jan 31, 2019	FY 2018 Jan 31, 2018	FY 2017 Jan 31, 2017	FY 2016 Jan 31, 2016	FY 2015 Jan 31, 2015	FY 2014 Jan 31, 2014
Assets
Cash	0 +51.8%	0 +86.5%	0 -95.5%	0 -86.8%	0	0	0 -100.0%	—	0 -95.7%	0 -85.9%	0
Cash and investments	0 +51.8%	0 +86.5%	0 -95.5%	0 -86.8%	0	0	0 -100.0%	—	0 -95.7%	0 -85.9%	0
Receivables	0	—	—	0	—	—	—	—	—	—	—
Inventory	0 -30.6%	0	—	—	0	—	—	—	—	—	—
Total current assets	0 -32.8%	0 +868.3%	0 -89.3%	0 -86.3%	0 +11.5%	0 +1227.4%	0 +4239.8%	—	0 -95.7%	0 -85.9%	0
Property and equipment, net	0 -89.1%	0 -61.5%	0 -22.6%	0	—	—	—	—	—	—	—
Total assets	0 -72.5%	0 -42.6%	0 -31.4%	0 +4.6%	0 +11.5%	0 +1227.4%	0	0 -100.0%	0 -95.7%	0 -85.9%	0
Liabilities and equity
Accounts payable	0	0	—	—	—	—	—	—	—	—	—
Total current liabilities	1 -27.1%	1 -34.2%	1 +15.2%	1 -2.9%	1 -18.7%	1 +69.7%	1 +19.0%	1 +58.0%	0 +16.7%	0 -1.1%	0
Total liabilities	1 -26.0%	1 -29.5%	1 +15.2%	1 -2.9%	1 -18.7%	1 +63.4%	1 +15.0%	1 +58.7%	0 +8.4%	0 -28.8%	1
Stockholders' equity	-1 +25.9%	-1 +39.2%	-1 -31.6%	-1 -13.9%	-1 +23.2%	-1 -44.6%	-1 -13.2%	-1 -58.8%	-0 -10.2%	-0 +23.5%	-1
Debt
Debt due within a year	—	—	—	—	—	—	—	—	—	—	0
Long-term debt	—	—	—	—	—	—	—	1 +7.8%	0	—	—
Total debt	—	—	—	—	—	—	—	1 +7.8%	0 +386.7%	—	0
Net cash	—	—	—	—	—	—	—	—	-0 -420.9%	—	-0
Ratios
Current ratio	0.02x	0.03x	0.00x	0.02x	0.18x	0.13x	0.02x	—	0.00x	0.02x	0.14x
Return on assets	-1,758.58%	-746.81%	-483.40%	-282.49%	-381.51%	-1,485.04%	-4,211.21%	—	-507,971.83%	-28,809.46%	-2,703.02%
Book value per share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.03	-0.11	-0.23	-0.25	-0.43	-0.03

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: NTRR (OTC)
Fiscal year ends: January 31
Incorporated in: WY
Headquarters: Houston, TX
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1512886

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.